According to ESSA Pharma's latest financial reports the company has S$0.17 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-09-30 | S$0.20 B | -15.49% |
2022-09-30 | S$0.23 B | -9.81% |
2021-09-30 | S$0.26 B | 147.67% |
2020-09-30 | S$0.10 B | 45.52% |
2019-09-30 | S$73.63 M | 263.37% |
2018-09-30 | S$20.26 M | 276.8% |
2017-09-30 | S$5.37 M | -56.14% |
2016-09-30 | S$12.26 M | 443.88% |
2015-09-30 | S$2.25 M | -52.18% |
2014-09-30 | S$4.71 M |